[Testicular germ cell tumors].

Abstract:

:Testicle germ cells tumors are the most common young men neoplasm. The incidence is maximal in Scandinavian countries. Cryptorchidism is a predisposing factor. Diagnosis is clinic, first treatment is radical orchidectomy by inguinal incision, after study of tumor markers. Histology shows seminoma or non seminomatous tumor. Carcinoma in situ is the precursor of invasive germ cell tumors. Germ cell tumors have no p53 mutation, and have isochrome of the short arm of chromosome 12 as a specific marker. With the results of histological, biochemical and radiographic evaluation, patient are classified as follows: good, intermediate and poor risk prognosis. Standard treatment of stage I seminoma is prophylactic irradiation. Stage II with less than 3 cm lymph node too. Other situations need a cisplatin based chemotherapy. In case of metastatic residuals masses more than 3 cm, surgery need to be discussed. Stage I non seminomatous germ cell tumors are treated by retroperitoneal lymphadenectomy, by surveillance or by two cycles of adjuvant chemotherapy with cisplatin, etoposide and bleomycin (BEP). Standard treatment of good prognosis stage II and III is three cycles of BEP, four for poor prognosis. Residual mass need surgery, adjuvant chemotherapy is necessary in presence of viable germ cell. Standard treatment for relapses is chemotherapy with cisplatin, ifosfamide and vinblastine with a 30% remission rate. The place of high dose chemotherapy with autologous stem cell transplantation is not yet standardised. New drugs, as paclitaxel, are under studies.

journal_name

Bull Cancer

journal_title

Bulletin du cancer

authors

Dourthe LM,Ouachet M,Fizazi K,Droz JP

subject

Has Abstract

pub_date

1998-09-01 00:00:00

pages

26-39

issue

1 Suppl

eissn

0007-4551

issn

1769-6917

pub_type

杂志文章,评审
  • [Tumor necrosis factor: pleiotropic cytokine].

    abstract::Originally described for its capacity to induce hemorrhagic necrosis of transplantable tumors in mice, TNF-alpha also exerts cytotoxic effects against some tumor cell lines in vitro. It is now known that TNF is an essential mediator of cellular immunity and a wide variety of biological activities of TNF in vitro and i...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Chouaib S,Robinet E,Zyad A,Branellec D

    更新日期:1992-01-01 00:00:00

  • [Metastatic stomach cancer: Clinical trials in Asia and in Occident].

    abstract::Although cytotoxic chemotherapy is the main therapeutic option to treat gastric cancer in the metastatic setting, molecular targeted agents have recently been introduced in an effort to improve survival outcomes which in average do not exceed 1 year. Trastuzumab and ramucirumab, antibodies directed against HER2 and VE...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2018.07.012

    authors: Bui QL,Grazziotin-Soares D,Hasiniatsy RE,Trinh HS,Richard S,Lotz JP,Gligorov J,Khalil A

    更新日期:2018-10-01 00:00:00

  • Is the proportion of hypoxic cells in a solid tumour dependent on the host (mouse or rat)?

    abstract::Hypoxic cell fraction was measured in a human tumour xenografted on two different animal species: mouse and rat. These results suggest that, while the Na11 tumour response to radiation depends on the host (nude mouse, nude rat), the proportion of hypoxic cells tested with the growth delay assay is independent of the h...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Guichard M,Chavaudra N,Malaise EP

    更新日期:1989-01-01 00:00:00

  • [Participation to organized screening programs: Individual and collective stakes].

    abstract::The evaluation of the risk-benefit balance in public health is an ethical commitment, based on the imperative of not harming people. Screening is a probabilistic approach, which, in order to serve the needs of a few, involves the largest number to share the potential harmful effects. Improvement of scientific knowledg...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2018.04.008

    authors: Launoy G,Duchange N,Darquy S,Moutel G

    更新日期:2019-01-01 00:00:00

  • Utilisation des inhibiteurs de PD-1 dans les hémopathies lymphoïdes.

    abstract::ANTI-PD-1 ANTIBODIES THERAPEUTIC USE IN LYMPHOID NEOPLASMS: Immune checkpoints blockade is under investigation in oncology, and has demonstrated its clinical efficacy. In hematology, immune checkpoints blockade is in earlier stages of development, but there are strong evidences of PD-1 blockade anti-tumor efficacy in ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/S0007-4551(16)30374-5

    authors: Bounaix L,Bendouda M,Bay JO,Lemal R

    更新日期:2016-11-01 00:00:00

  • [Chemotherapy-induced peripheral neuropathy: Symptomatology and epidemiology].

    abstract::Chemotherapy-induced peripheral neuropathy (CIPN) is common with specific semiological characteristics. When CIPN appears, there are many difficulties in guaranteeing sustained treatment, especially with optimal protocol. Moreover, CIPN have bad repercussions on quality of life after cancer disease. In this article, w...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2018.07.009

    authors: Kerckhove N,Collin A,Condé S,Chaleteix C,Pezet D,Balayssac D,Guastella V

    更新日期:2018-11-01 00:00:00

  • [Malignant cardiac tumors].

    abstract::Cardiac neoplasms are a rare occurrence in clinical practice. The various frequencies of primary and secondary malignant tumors vary from report to report, approximately 1% in most autopsy series and 4% in cancer patient's autopsies. Cardiac malignancies account for less 1% of cardiac surgery and about for 0.1% of car...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Debourdeau P,Gligorov J,Teixeira L,Aletti M,Zammit C

    更新日期:2004-11-01 00:00:00

  • [What's new in the treatment of cancer pain?].

    abstract::Improvements have been made recently in the treatment of cancer pain. First of all, this symptom is better recognized and evaluated in cancer patients. Then new therapeutic options have became available in France : tramadol, WHO level II analgesic, for intermediate to severe pain; gabapentine, a new anticonvulsivant d...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Di Palma M,Poulain P,Pichard E

    更新日期:2004-01-01 00:00:00

  • [Current trends in lung cancer mortality in France].

    abstract::Lung cancer is the first cause of death from cancer in males in France. This cancer is responsible for 19,000 deaths in males and 3,000 deaths in females. We studied the geographical and temporal variations in lung cancer mortality in France. The average increase in mortality clearly decreased in males, changing from ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Rezvani A,Doyon F

    更新日期:1996-11-01 00:00:00

  • [Sentinel node biopsy in breast cancer].

    abstract::As compared to conventional axillary dissection, the sentinel node technique is accompanied by reduced morbidity and shorter hospital stay. Based on available data, the use of this technique does not seem to yield higher rates of axillary recurrence. A combination of both radioisotope detection and blue dye increases ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2009.0879

    authors: Hindié E,Groheux D,Espie M,Bourstyn E,Toubert ME,Sarandi F,de Roquancourt A,Giacchetti S,Cuvier C,Cahen-Doidy L,Teyton P,Misset JL,Maylin C,Moretti JL

    更新日期:2009-06-01 00:00:00

  • [Pharmacological consequences of the targeting of epidermal growth factor receptor].

    abstract::Through clearly identified molecular mechanisms, EGFR targeting leads to cell physiology modifications as cell proliferation, apoptosis and DNA repair. These mechanisms can explain the proper activity of EGFR targeting drugs but also represent a strong rational basis on which several experimental studies have been des...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Milano G,Magné N

    更新日期:2003-11-01 00:00:00

  • Evaluation of multidrug resistant phenotype by flow cytometry with monoclonal antibodies and functional tests.

    abstract::Multidrug resistant (MDR) phenotype is characterized by a defect in drug accumulation caused by overexpression of a transmembrane glycoprotein, the P-glycoprotein (P-gp). MDR phenotype can be characterized either with monoclonal antibodies raised against P-gp or with functional tests, most often based on the incorpora...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Lizard G,Maynadié M,Roignot P,Lizard-Nacol S,Poupon MF

    更新日期:1995-03-01 00:00:00

  • [Angiopoietin-2, a new molecular actor involved in vascular tree morphogenesis].

    abstract::Angiopoietin-2 is a new member of the family of the ligands of Tek (Tie2), a transmembrane receptor with tyrosine kinase activity which is specifically expressed in endothelial cells during angiogenesis. Several lines of evidence indicate that angiopoietin-1 is involved in pericyte recruitment by endothelial cells and...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Vandenbunder B

    更新日期:1997-11-01 00:00:00

  • [Hepatocellular carcinoma: Increase in incidence or future plague?]

    abstract::Hepatocellular carcinoma is the third most frequent cause of cancer death worldwide, particularly in Asia and Africa. Most cases complicate an underlying liver cirrhosis due to hepatitis B or C chronic virus infection or alcoholic abuse. But, following the current epidemics of obesity and type 2 diabetes, it appears t...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2018.02.003

    authors: Raoul JL,Raimbourg J,Hiret S,Adhoute X,Senellart H

    更新日期:2018-05-01 00:00:00

  • [Management of febrile neutropenias in adolescents and young adults: Differences of practice between adult and pediatric units].

    abstract:INTRODUCTION:Adolescents and young adults (AYA, 15-25years old) with cancer are treated either in adult or pediatric units. Management of febrile neutropenia (FN) is different between these units. Monitoring rules and indications of hospitalization are often stricter in pediatrics. This study evaluates if these differe...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2015.08.001

    authors: Penel-Page M,Normand C,Bertrand A,Levard A,Boyle H,Riberon C,Marec-Berard P

    更新日期:2015-11-01 00:00:00

  • [Following communications made at American Society of Clinical Oncology 2010, what will change our practice? The point of view of the editorial board of Bulletin du Cancer].

    abstract::The congress of Asco made the object of numerous summaries of congress made in the heat of the moment and the Bulletin du Cancer decided to ask to his editorial board, a digested summary, at distance of the congress, to try to sum up the data of the congress which are going to change practice. Of the considerable numb...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2010.1221

    authors: André T,Wislez M,Goncalves A,de La Motte Rouge T,Blay JY,Massard C,Bay JO,comité de rédaction du Bulletin du Cancer.

    更新日期:2010-12-01 00:00:00

  • [Gastrointestinal stromal tumours in pediatrics: a summary of the literature on this orphan disease].

    abstract::Recommendations for the management of gastrointestinal stromal tumours (GIST) in children and adolescents do presently not exist. Thus, a summary of the current literature was conducted serving as a basis for the development of optimal management strategies for childhood GIST. Pediatric cases of GIST may occur sporadi...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2010.1296

    authors: Verschuur A,André N,Blay JY

    更新日期:2011-01-01 00:00:00

  • [Cellular immunotherapy: complexity of immune system and industrial development].

    abstract::Cell immunotherapy aims at treating patients by stimulating their own immune system using appropriate cells. This approach is one of the most promising therapeutic strategy against cancer. The use of cells, the mobilization of a system, the targeting of interactions between the immune system and the tumor constitute t...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Abastado JP

    更新日期:2003-08-01 00:00:00

  • [Prognostic factors in multiple myeloma. Review of the literature].

    abstract::Apparition of new tools in the therapy of multiple (MM) strengthens the need for valuable prognostic categorization of each patient in order to propose the most adequate treatment. Prognostic factors in MM can be divided in four groups. The first, including beta 2 microglobulin (beta 2m), hemopoiesis impairment, osteo...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Bauduer F,Troussard X,Delmer A

    更新日期:1993-12-01 00:00:00

  • [Opioid switch and change of route of administration in cancer patients treated by morphine].

    abstract::This paper reviewed the 2002 guidelines established by the National Federation of Cancer Centres. A group of experts nominated by the 3 French Societies involved in the treatment of cancer pain (AFSOS, SFAP, SFETD), established new guidelines ratios for morphine switching and/or changing of route of administration, in...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,实务指引,评审

    doi:10.1016/j.bulcan.2018.06.011

    authors: Michenot N,Rostaing S,Baron L,Faure S,Jovenin N,Hubault P,Delorme T,Collin E,Filbet M,Chvetzoff G,Delorme C,Minello C,Magnet M,Ammar D,Krakowski I,Poulain P

    更新日期:2018-11-01 00:00:00

  • [Impact of [18F]-FDG-PET on medical decision making in oncology: evaluation by the referring physicians during the opening year].

    abstract::The first study evaluating directly by the referring physician the clinical impact of [18F]-FDG-PET on modification of patient's management was performed only recently in California by means of a questionnaire. We have used the same methodology to evaluate this clinical impact during the opening year of our PET centre...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Talbot JN,Rain JD,Meignan M,Askienazy S,Grall Y,Bok B,Misset JL

    更新日期:2002-03-01 00:00:00

  • [Integrins, cell response to anti-tumor agents and chemoresistance].

    abstract::Integrins are a family of heterodimeric transmembrane receptors that mediate cell-cell and cell-extracellular matrix adhesion. Integrin-mediated signaling is essential for the regulation of fundamental cellular functions, including proliferation and survival, and for tumor development. According to in vitro studies, i...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Maubant S,Staedel C,Gauduchon P

    更新日期:2002-11-01 00:00:00

  • [Combination of chemotherapy (vindesine, lomustine, cisplatin, cyclophosphamide) and thoracic radiotherapy in nonresectable non-small cell bronchial carcinoma: final results of a phase II clinical trial].

    abstract::Seventy-five patients with locally advanced non small cell lung carcinoma were entered in a phase II study combining chemotherapy (vindesine, lomustine, cisplatin and cyclophosphamide) and radical thoracic radiotherapy delivering a total dose of 60-65 Gy. Patients were regularly assessed by radiological and fiberoptic...

    journal_title:Bulletin du cancer

    pub_type: 临床试验,杂志文章

    doi:

    authors: Nasr E,Pellae-Cosset B,Arriagada R,Le Chevalier T,Baldeyrou P,Ruffie P,de Cremoux H,Martin M,Tarayre M

    更新日期:1992-01-01 00:00:00

  • Genetics of familial atypical multiple mole-melanoma (FAMMM) syndrome in The Netherlands: how far have we come?

    abstract::By the genetic localization of the first melanoma susceptibility gene on chromosome 1p we thought that the puzzle on familial melanoma families would soon be solved. Now, almost fifteen years later we have learned that inherited melanoma is not a simple genetic disorder and that multiple genes, modifying genes and env...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Gruis NA,Van der Velden PA,Bergman W,Frants RR

    更新日期:1998-07-01 00:00:00

  • [Prevention and treatment of antineoplastic drug-induced nausea and vomiting in pediatric onco-hematology: An update].

    abstract::Antineoplastic drug induced nausea and vomiting are common adverse events in cancer care of paediatric patients ; therefore, prevention and management of these adverse events is a major concern for healthcare professionals. There are common features between paediatric and adult patients in terms of the emetogenic leve...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2020.03.015

    authors: Delmotte M,Mouffak S,Mongaret C,Michelet-Huot E,Roques G,Slimano F

    更新日期:2020-01-01 00:00:00

  • [Assessment of HER2 status in breast cancer].

    abstract::HER2-positive status is the sole criterion for identifying patients with breast cancer for Herceptin (trastuzumab) therapy. Accurate assessment of HER2 status is essential to ensure that all patients who may benefit from Herceptin are correctly identified. There are several assays available to determine HER2 status: t...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Penault-Llorca F,Cayre A

    更新日期:2004-12-01 00:00:00

  • [Management of analgesics in cancer patients with renal impairment].

    abstract::Pain is frequent in cancer patients. To date, there is a consequent therapeutic arsenal so to manage pain; the different treatment strategies are the subject of various recommendations. Patients with cancer also frequently suffer from renal insufficiency, and this comorbidity may disrupt or jeopardize the analgesic st...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2011.1488

    authors: Rey JB,Tran T,Ammar D,Parent D,Janus N,Launay-Vacher V

    更新日期:2012-03-01 00:00:00

  • [PNET/Ewing tumours: current treatments and future perspectives].

    abstract::Ewing tumours are characterised as tumours consisting of small, blue, round malignant cells that may exhibit varying degrees of neural differentiation. Most of them arise in bony sites, and they represent the second commonest primary osseous malignancy in and adolescence and young adults. During the past 30 years, che...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2010.1120

    authors: Marec-Bérard P,Chotel F,Claude L

    更新日期:2010-06-01 00:00:00

  • [Hepatic transport of mitoxantrone in relation to multiple resistance].

    abstract::We have examined the effect of cyclosporin A on transport processes (uptake, efflux, binding) of mitoxantrone in isolated rat liver cells. Accumulation and binding of mitoxantrone was rapid with or without cyclosporin A. The initial uptake was linear over a wide concentration range (1 to 1000 microM). For the first 10...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Coloma F,Lacarelle B,Poitou P,Filleul A,Covo J,Catalin J

    更新日期:1994-05-01 00:00:00

  • [Irinotecan for the treatment of metastatic colorectal cancer].

    abstract::In a dozen years of development, irinotecan (CPT11) became one of major therapeutics in the taking care of the metastatic colorectal cancer (CCRM). First used in monotherapy every three weeks, irinotecan has been later developed in association with 5FU and folinic acid according to two modalities of administration (bo...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Assenat E,Duffour J,Ychou M

    更新日期:2006-05-01 00:00:00